CLINICAL STUDIES
Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine
Sara Thorne, MDa,
Michael J. Mullen, MBBSa,
Peter Clarkson, MBBSa,
Ann E. Donalda and
John E. Deanfield, FRCPa
a Vascular Physiology Unit, Great Ormond Street Hospital for Children, London, England, United Kingdom
Manuscript received October 15, 1997;
revised manuscript received March 9, 1998,
accepted April 9, 1998.
Address for correspondence: Dr. John E. Deanfield, Vascular Physiology Unit, Great Ormond Street Hospital for Children, London WC1N 3JE, England, United Kingdom
101723.523{at}compuserve.com
Objectives. We sought to examine endothelial responses to L-arginine in three groups with isolated risk factors: hypercholesterolemia, smoking and insulin-dependent diabetes mellitus (IDDM).
Background. Endothelial dysfunction occurs early in atherosclerosis, predating clinical disease. We hypothesized that the nature of endothelial injury associated with individual cardiovascular risk factors might be different and that this might affect the response to L-arginine, the substrate for endothelial nitric oxide synthase.
Methods. We studied the effects of intravenous L-arginine on brachial artery flow-mediated dilation (FMD) and glyceryl trinitrate (GTN)–mediated dilation in 36 young subjects (18 to 40 years old) without clinical atherosclerosis: 9 each of normal control subjects, hypercholesterolemic subjects, cigarette smokers and subjects with IDDM.
Results. Baseline FMD was significantly impaired in hypercholesterolemic subjects (mean ± SD 1.7 ± 2.3%), smokers (1.6 ± 1.8%) and diabetic subjects (1.8 ± 1.5%) compared with that in control subjects (6.9 ± 3.3%, p = 0.001). The response to GTN was not significantly different between the subjects with risk factors and control subjects, apart from those with IDDM, in whom it was significantly impaired (p = 0.026). After infusion of L-arginine, there was no change in FMD in control or diabetic subjects. In hypercholesterolemic subjects and smokers, FMD improved from 1.9 ± 1.9% to 4.1 ± 2.1% (p = 0.01) and from 2.0 ± 1.71% to 3.1 ± 2.5% (p = 0.02), respectively.
Conclusions. FMD was impaired in all three risk factor groups; however, they responded differently to L-arginine, FMD being improved in hypercholesterolemic subjects and smokers but unchanged in diabetic subjects. These results indicate differing underlying pathophysiologies that may facilitate the design of treatment strategies for subjects with different risk factors.
|
Abbreviations and Acronyms
| | ADMA | = asymmetric dimethyl arginine | | ANOVA | = analysis of variance | | FMD | = flow-mediated dilation | | GTN | = glyceryl trinitrate | | HbA1 | = glycosylated hemoglobin | | HDL | = high density lipoprotein | | IDDM | = insulin-dependent diabetes mellitus | | LDL | = low density lipoprotein | | NO | = nitric oxide |
|
This article has been cited by other articles:
|
|
|
|
 
D. Wang, S. Strandgaard, J. Iversen, and C. S. Wilcox
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2009;
296(2):
R195 - R200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sumiyoshi, H. Mokuno, T. Iesaki, K. Shimada, T. Miyazaki, A. Kume, T. Kiyanagi, K. Kuremoto, Y. Watanabe, N. Tada, et al.
Deletion of the Fc receptors {gamma} chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet
Cardiovasc Res,
December 1, 2008;
80(3):
463 - 470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al.
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
Cardiovasc Res,
November 1, 2008;
80(2):
165 - 174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Patel and R. R. Arora
Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease
Therapeutic Advances in Cardiovascular Disease,
April 1, 2008;
2(2):
89 - 100.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. A. Costa, S. Shoemaker, H. Futamatsu, C. Klassen, D. J. Angiolillo, M. Nguyen, A. Siuciak, P. Gilmore, M. M. Zenni, L. Guzman, et al.
Quantitative Magnetic Resonance Perfusion Imaging Detects Anatomic and Physiologic Coronary Artery Disease as Measured by Coronary Angiography and Fractional Flow Reserve
J. Am. Coll. Cardiol.,
August 7, 2007;
50(6):
514 - 522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Yang, K. Venardos, E. Jones, B. J. Morris, J. Chin-Dusting, and D. M. Kaye
Identification of a Novel Polymorphism in the 3'UTR of the L-Arginine Transporter Gene SLC7A1: Contribution to Hypertension and Endothelial Dysfunction
Circulation,
March 13, 2007;
115(10):
1269 - 1274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Gates, M. L. Boucher, A. E. Silver, K. D. Monahan, and D. R. Seals
Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression
J Appl Physiol,
January 1, 2007;
102(1):
63 - 71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Perticone, A. Sciacqua, R. Maio, M. Perticone, R. Maas, R. H. Boger, G. Tripepi, G. Sesti, and C. Zoccali
Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension
J. Am. Coll. Cardiol.,
August 2, 2005;
46(3):
518 - 523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Schneider, A. U. Klingbeil, C. Delles, B. M. W. Schmidt, S. John, and R. E. Schmieder
Vitamin C augments the renal response to L-arginine in smokers
Nephrol. Dial. Transplant.,
August 1, 2003;
18(8):
1512 - 1517.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Schneider, A. U. Klingbeil, C. Delles, B. M. W. Schmidt, S. John, and R. E. Schmieder
Vitamin C augments the renal response to L-arginine in smokers
Nephrol. Dial. Transplant.,
August 1, 2003;
18(88):
1512 - 1517.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Browne, D. Meeking, K. Shaw, and M. Cummings
Review: Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes -- pathogenesis and identification
The British Journal of Diabetes & Vascular Disease,
January 1, 2003;
3(1):
27 - 34.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst,
October 2, 2002;
94(19):
1435 - 1444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tousoulis, C. Antoniades, C. Tentolouris, G. Goumas, C. Stefanadis, and P. Toutouzas
L-Arginine in cardiovascular disease: dream or reality?
Vascular Medicine,
August 1, 2002;
7(3):
203 - 211.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Vascular Medicine,
August 1, 2002;
7(3):
213 - 225.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. C. Colombo, A. W. Ashton, S. Celaj, A. Talreja, J. E. Banchs, N. B. Dubois, M. Marinaccio, S. Malla, J. Lachmann, J. A. Ware, et al.
Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium
J Appl Physiol,
March 1, 2002;
92(3):
1331 - 1338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Corretti, T. J. Anderson, E. J. Benjamin, D. Celermajer, F. Charbonneau, M. A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, et al.
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
J. Am. Coll. Cardiol.,
January 16, 2002;
39(2):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei
Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1083 - 1088.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Spacil, R. Ceska, and T. Haas
Flow-Dependent Vasomotor Dysfunction of the Popliteal Artery Related to Common Carotid Artery Intima-Media Thickness
Angiology,
October 1, 2001;
52(10):
689 - 695.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D Tousoulis, G J Davies, C Tentolouris, G Goumas, C Stefanadis, and P Toutouzas
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque
Heart,
September 1, 2001;
86(3):
296 - 301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Babaei, P. Picard, A. Ravandi, J. C. Monge, T. C. Lee, P. Cernacek, and D. J. Stewart
Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation
Cardiovasc Res,
October 1, 2000;
48(1):
158 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Hirai, H. Kawano, O. Hirashima, T. Motoyama, Y. Moriyama, T. Sakamoto, K. Kugiyama, H. Ogawa, K. Nakao, and H. Yasue
Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C
Am J Physiol Heart Circ Physiol,
September 1, 2000;
279(3):
H1172 - H1178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Mullen, D. Wright, A. E. Donald, S. Thorne, H. Thomson, and J. E. Deanfield
Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
410 - 416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Padilla, D. Garcia-Dorado, L. Agullo, J. Inserte, A. Paniagua, S. Mirabet, J. A. Barrabes, M. Ruiz-Meana, and J. Soler-Soler
L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig
Cardiovasc Res,
June 1, 2000;
46(3):
412 - 420.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Fike, M. R. Kaplowitz, L. A. Rehorst-Paea, and L. D. Nelin
L-Arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs
J Appl Physiol,
May 1, 2000;
88(5):
1797 - 1803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ueda, H. Matsuoka, H. Miyazaki, M. Usui, S. Okuda, and T. Imaizumi
Tetrahydrobiopterin restores endothelial function in long-term smokers
J. Am. Coll. Cardiol.,
January 1, 2000;
35(1):
71 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. O'Driscoll, D. Green, A. Maiorana, K. Stanton, F. Colreavy, and R. Taylor
Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1506 - 1511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Knight-Lozano, C. G. Young, D. L. Burow, Z. Y. Hu, D. Uyeminami, K. E. Pinkerton, H. Ischiropoulos, and S. W. Ballinger
Cigarette Smoke Exposure and Hypercholesterolemia Increase Mitochondrial Damage in Cardiovascular Tissues
Circulation,
February 19, 2002;
105(7):
849 - 854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
